Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking

Acta Oncologica

Volumn 50, Issue 6, 2011, Pages 777-783

  Rosenschöld, Per Munck Af ^a   Engelholm, Silke ^a   Ohlhues, Lars ^a   Law, Ian ^a   Vogelius, Ivan ^a   Engelholm, Svend Aage ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOBUTROL;

ARTICLE; BRAIN; BRAIN STEM; CANCER CHEMOTHERAPY; CANCER PATIENT; CHIASMATIC CISTERN; CLINICAL ARTICLE; COLLIMATOR; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFUSION TENSOR IMAGING; EYE; GLIOBLASTOMA; HIPPOCAMPUS; HUMAN; INNER EAR; INTENSITY MODULATED PROTON THERAPY; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; INVERSELY OPTIMIZED ARC THERAPY; LINEAR ACCELERATOR; MULTILEAF COLLIMATOR; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGANS AT RISK; PLANNING TARGET VOLUME; PRIORITY JOURNAL; PROTON THERAPY; STANDARD; TREATMENT PLANNING; VOLUMETRY;

BRAIN NEOPLASMS; DIFFUSION TENSOR IMAGING; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; ORGANS AT RISK; PHOTONS; POSITRON-EMISSION TOMOGRAPHY; PROTONS; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79960551081     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2011.584555     Document Type: Article

References (33)

1. McLendon RE, Rich JN. Glioblastoma stem cells: A neu-ropathologist's view. J Oncol 2011;2011:397195.
2. Salford LG, Brun A, Nirfalk S. Ten-year survival among patients with supratentorial astrocytomas grade III and IV. J Neurosurg 1988;69:506-9.
3. Gilbert MR, Friedman HS, Kuttesch JF, Prados MD, Olson JJ, Reaman GH, et al. A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant gli-oma before radiation therapy. Neuro Oncol 2002;4:261-7.
4. Curran WJ, Jr., Scott CB, Weinstein AS, Martin LA, Nelson JS, Phillips TL, et al. Survival comparison of radiosurgery-eligible and-ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: A report of Radiation Therapy Oncology Group 83-02. J Clin Oncol 1993;11:857-62. (Pubitemid 23146079)
5. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96. (Pubitemid 40349501)
6. Narayana A, Yamada J, Berry S, Shah P, Hunt M, Gutin PH, et al. Intensity-modulated radiotherapy in high-grade glio-mas: Clinical and dosimetric results. Int J Radiat Oncol Biol Phys 2006;64:892-7. (Pubitemid 43183590)
7. Shirai K, Suzuki Y, Okamoto M, Wakatsuki M, Noda SE, Takahashi T, et al. Infl uence of histological subtype on sur-vival after combined therapy of surgery and radiation in WHO grade 3 glioma. J Radiat Res (Tokyo) 2010;51:589-94.
8. Evers P, Lee PP, DeMarco J, Agazaryan N, Sayre JW, Selch M, et al. Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma BMC. Cancer 2010;10:384.
9. Thilmann C, Zabel A, Grosser KH, Hoess A, Wannenmacher M, Debus J. Intensity-modulated radiotherapy with an inte-grated boost to the macroscopic tumor volume in the treat-ment of high-grade gliomas. Int J Cancer 2001;96:341-9. (Pubitemid 33136287)
10. MacDonald SM, Ahmad S, Kachris S, Vogds BJ, DeRouen M, Gittleman AE, et al. Intensity modulated radiation ther-apy versus three-dimensional conformal radiation therapy for the treatment of high grade glioma: A dosimetric compari-son. J Appl Clin Med Phys 2007;8:47-60.
11. Hermanto U, Frija EK, Lii MJ, Chang EL, Mahajan A, Woo SY. Intensity-modulated radiotherapy (IMRT) and con-ventional three-dimensional conformal radiotherapy for high-grade gliomas: Does IMRT increase the integral dose to normal brain? Int J Radiat Oncol Biol Phys 2007;67:1135-44.
12. Chan MF, Schupak K, Burman C, Chui CS, Ling CC. Com-parison of intensity-modulated radiotherapy with three-dimensional conformal radiation therapy planning for gliob-lastoma multiforme. Med Dosim 2003;28:261-5. (Pubitemid 37543688)
13. Wagner D, Christiansen H, Wolff H, Vorwerk H. Radiotherapy of malignant gliomas: Comparison of volumetric single arc technique (RapidArc), dynamic intensity-modulated technique and 3D conformal technique. Radiother Oncol 2009;93:593-6.
14. Shaffer R, Nichol AM, Vollans E, Fong M, Nakano S, Moi-seenko V, et al. A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas. Int J Radiat Oncol Biol Phys 2010;76:1177-84.
15. Aznar MC, Petersen PM, Logadottir A, Lindberg H, Korre-man SS, Kjaer-Kristoffersen F, et al. Rotational radiotherapy for prostate cancer in clinical practice. Radiother Oncol 2010;97:480-4.
16. Kjaer-Kristoffersen F, Ohlhues L, Medin J, Korreman S. RapidArc volumetric modulated therapy planning for pros-tate cancer patients. Acta Oncol 2009;48:227-32.
17. Korreman S, Medin J, Kjaer-Kristoffersen F Dosimetric verifi cation of RapidArc treatment delivery. Acta Oncol 2009;48:185-91.
18. Fredh A, Korreman S, Munck af Rosenschold P. Automated analysis of images acquired with electronic portal imaging device during delivery of quality assurance plans for inversely optimized arc therapy. Radiother Oncol 2010;94:195-8.
19. Abayomi OK Pathogenesis of irradiation-induced cognitive dysfunction. Acta Oncol 1996;35:659-63. (Pubitemid 26366721)
20. Monje ML, Mizumatsu S, Fike JR, Palmer TD. Irradiation induces neural precursor-cell dysfunction. Nat Med 2002; 8:955-62. (Pubitemid 35033699)
21. Sanghvi DA. Recent advances in imaging of brain tumors. Indian J Cancer 2009;46:82-7.
22. Pedroni E, Scheib S, Bohringer T, Coray A, Grossmann M, Lin S, et al. Experimental characterization and physical mod-elling of the dose distribution of scanned proton pencil beams. Phys Med Biol 2005;50:541-61. (Pubitemid 40297924)
23. Munck af Rosenschold P, Aznar MC, Nygaard DE, Persson GF, Korreman SS, Engelholm SA, et al. A treatment plan-ning study of the potential of geometrical tracking for inten-sity modulated proton therapy of lung cancer. Acta Oncol 2010; 49: 1141-8.
24. Yoon M, Park SY, Shin D, Lee SB, Pyo HR, Kim DY, et al. A new homogeneity index based on statistical analysis of the dose-volume histogram. J Appl Clin Med Phys 2007;8: 9-17.
25. Amelio D, Lorentini S, Schwarz M, Amichetti M. Intensity-modulated radiation therapy in newly diagnosed glioblast-oma: A systematic review on clinical and technical issues. Radiother Oncol 2010;97:361-9.
26. Shaffer R, Nichol AM, Vollans E, Fong M, Nakano S, Moi-seenko V, et al. A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas. Int J Radiat Oncol Biol Phys 2010;76:1177-84.
27. Wagner D, Christiansen H, Wolff H, Vorwerk H. Radiother-apy of malignant gliomas: Comparison of volumetric single arc technique (RapidArc), dynamic intensity-modulated technique and 3D conformal technique. Radiother Oncol 2009;93:593-6.
28. Lawrence YR, Li XA, El Naqa I, Hahn CA, Marks LB, Mer-chant TE, et al. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S20-7.
29. Maruyama K, Kamada K, Ota T, Koga T, Itoh D, Ino K, et al. Tolerance of pyramidal tract to gamma knife radiosur-gery based on diffusion-tensor tractography. Int J Radiat Oncol Biol Phys 2008;70:1330-5. (Pubitemid 351417748)
30. Mabbott DJ, Noseworthy MD, Bouffet E, Rockel C, Laugh-lin S. Diffusion tensor imaging of white matter after cranial radiation in children for medulloblastoma: Correlation with IQ. Neuro Oncol 2006;8:244-52. (Pubitemid 46542649)
31. Gondi V, Tome WA, Mehta MP. Why avoid the hippocampus? A comprehensive review. Radiother Oncol 2010;97:370-6.
32. Henriksson R, Asklund T, Poulsen HS. Impact of therapy on quality of life, neurocognitive function and their corre-lates in glioblastoma multiforme: A review. J Neurooncol Epub 2011 Apr 6.
33. Ottosson RO, Engstrom PE, Sjostrom D, Behrens CF, Karls-son A, Knoos T, et al. The feasibility of using Pareto fronts for comparison of treatment planning systems and delivery techniques. Acta Oncol 2009;48:233-7.